Actavis has more than 10,000 employees operating in about 40 countries around the globe. Its headquarters are in Iceland.

The Actavis Group maintains modern development and manufacturing facilities in Europe, the US and Asia.

These plants produce a range of medicines in various formulations, including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids.

Research & Development sites in Iceland, India, Malta, Romania and the United States.

Manufacturing sites in Bulgaria, China, Iceland, India, Indonesia, Italy, Malta, Norway, Romania, Russia, Serbia, Turkey, the United Kingdom and the United States.

Sales & Marketing offices and a growing sales network in Europe, North America and other markets continues to increase access to Actavis products. In addition, Actavis operates a third party sales division called Medis, which sells finished products, dossiers and APIs to third party pharmaceutical companies worldwide.

The sales divisions are supported by operational functions on a global basis.

A global team of experienced senior managers from seven different nationalities, with significant industry experience, supports Actavis' CEO across the Company’s commercial and operational divisions.

Actavis Group is headquartered in Hafnarfjordur, Iceland.